Intravascular catheters

Information

  • Patent Grant
  • 12144977
  • Patent Number
    12,144,977
  • Date Filed
    Tuesday, February 12, 2019
    5 years ago
  • Date Issued
    Tuesday, November 19, 2024
    2 days ago
  • CPC
    • A61M60/829
    • A61M60/13
    • A61M60/135
    • A61M60/216
    • A61M60/414
    • A61M60/416
    • A61M60/833
    • A61M60/857
  • Field of Search
    • CPC
    • A61M60/205
    • A61M60/414
    • A61M60/40
    • A61M1/0058
    • A61M25/0662
  • International Classifications
    • A61M60/13
    • A61M60/135
    • A61M60/216
    • A61M60/414
    • A61M60/416
    • A61M60/829
    • A61M60/833
    • A61M60/857
    • Term Extension
      0
Abstract
The disclosure provides an intravascular catheter with a purge system that excludes biological fluids and may also include devices such as impellers that can be delivered over, and operated over, a guidewire. Catheters may include treatment devices suited to the treatment of edema and in which the guidewire aids in positioning the device while the purge system facilitates reliable operation.
Description
FIELD OF THE INVENTION

The disclosure relates to intravascular catheters having a purge system, and optionally, a guidewire lumen through an impeller.


BACKGROUND

Congestive heart failure is the result of a weakened heart. As blood flow out of the heart slows, blood returning to the heart backs up and increases in pressure in the veins, inhibiting drainage from the lymphatic system, causing congestion in the body, resulting in edema. Edema may manifest as visible swelling in a person's legs and ankles, and can be present in other parts of the body as well. Sometimes fluid collects in the lungs and interferes with breathing. This is called pulmonary edema and can be particularly distressing. Heart failure also affects the ability of the kidneys to dispose of sodium and water and the retained water also contributes to the edema.


Congestive heart failure and edema may potentially be treated using drugs or medical devices. For example, intravascular catheters may potentially be used to assist in draining the lymphatic system or pumping blood. Such catheters may be designed with mechanical components such as pumps or inflatable balloons.


Intravascular treatment using catheters with mechanical components presents a variety of challenges. For example, intravascular catheters having mechanical parts typically have joints or different connection points that couple different mechanical elements of the catheter. Those joints or connection points serve as locations where body fluid, e.g., blood and/or lymph, can enter or leak into the catheter. Blood and lymph contain live cells, dead cells, fragments of lipids, free nucleic acids, and other materials. Those materials can interfere with the reliable functioning of an intravascular device, particularly operation of rotating mechanical parts. Additionally, the body fluid that enters the catheter could possibly travel to a proximal portion of the catheter outside of the patient's body, where it could leak out of the catheter, creating an unsterile situation for the patient and care providers.


SUMMARY

The disclosure provides intravascular catheters having mechanical components, e.g., an impeller and/or drive shaft, and a purge system. The purge system operates to exclude biological fluids and materials from the catheter and mechanical components operating within the catheter. In that manner, the intravascular catheters of the invention are able to prevent body fluid from entering the catheter, ensuring smooth and efficient operation of the mechanical parts, e.g., impeller and drive shaft, within the catheter while also preventing the patient's body fluid from travelling to a proximal portion of the catheter outside of the patient's body, where it could leak out of the catheter.


In certain aspects, a distal portion of a catheter can be dimensioned for insertion into a blood vessel. The catheter can be equipped with an impeller coupled to a rotating drive shaft. As will be discussed below, the catheter can have additional features to restrict flow or to aid flow, such as inflatable balloons or pumps. The catheter is also equipped with a purge system that can use, for example, a purge fluid to prevent blood, lymph, or other biological materials from entering mechanical parts of the catheter, e.g., motor, impeller, driver shaft, etc. The purge system of the disclosure excludes bodily fluids from the catheter both while the devices are not deployed or not operating and while such devices are deployed or operating. For example, the catheter can be purged by a purge fluid under hydrostatic pressure that excludes bodily fluid while a physician is navigating the catheter to the desired location. In embodiments in which the catheter includes a device such as an impeller, centrifugal force can be exploited to wash the impeller and associated motor during operation of the device.


In certain embodiments, the device includes a catheter dimensioned for insertion into a bodily lumen, a porous drive shaft extending from a motor and through the catheter, in which a portion of the drive shaft is housed within a tube comprising one or more through holes, and an infusion channel in fluid communication with the porous drive shaft and arranged such that purge fluid is discharged through the porous drive shaft and through the through holes of the tube. A proximal end of the tube includes a proximal sealed connection around the drive shaft. Operation of the motor rotates the drive shaft within the tube. A distal end of the tube may include a distal sealed connection around the drive shaft. The device may further include one or more inflatable balloons disposed along the catheter, each in fluid communication with an inflation lumen extending along the catheter.


When the motor is not rotating, a static pressure of the purge fluid prevents bodily fluid from entering the housing. When the motor is rotating, the purge fluid is subject to centrifugal force along the drive shaft preventing bodily fluid from approaching the proximal portion of the catheter. The motor may include a rotor disposed within a stator in a housing at a proximal portion of the catheter. The porous drive shaft may be coupled to, and extending from, the rotor.


Preferably, when the impeller is inserted into vasculature of a patient, the proximal sealed connection, the tube, and/or the distal sealed connection separate the purge fluid within the porous drive shaft from blood within the catheter outside of the tube.


In some embodiments, the impeller has one or more blades disposed along an impeller shaft coupled to the drive shaft, in which the impeller shaft has an impeller shaft lumen therethrough and one or more holes along a side of the impeller shaft such that rotation of the impeller in a liquid subjects the liquid to centrifugal force at the one or more holes. When rotating, the purge fluid is driven by centrifugal force outward through the through-holes along the impeller shaft such that the purge fluid continually washes the impeller. In certain embodiments, when the impeller is disposed within vasculature of a patient and the motor is operated, the impeller pumps blood and the purge fluid rinses at least a portion of the impeller.


The disclosure additionally provides intravascular catheters with treatment devices such as impellers that can be delivered over, and operated over, a guidewire, to aid in operating intravascular treatment devices in the correct location and orientation within a body. That is, in certain aspects, the invention provides intravascular impeller based devices in which the impeller has a guidewire channel there through and the impeller can operate while a guidewire is extended through the impeller within the guidewire channel. As discussed herein, catheters of the disclosure may include additional features that operate to restrict flow, to assist flow, or both. A physician can navigate a guidewire to an intended treatment location and manually refine the positioning of the guidewire. The device is loaded onto the guidewire via the guidewire channel that passes through the impeller. The device is then pushed over the guidewire to the intended location. Exemplary embodiments include a catheter with one or more flow restrictors, such as inflatable balloons, and a pump or impeller, in which the flow restrictors create a low pressure zone around an output of a thoracic duct while the impeller aids in draining the lymphatic system. The inflatable balloons and the impeller can be deployed and operated, respectively, even while the guidewire extends through a guidewire lumen that passes through the impeller.


By including over-the-wire treatment devices on an intravascular catheter, in which those devices can be deployed and operated while the catheter is being navigated over a guidewire, the disclosure provides intravascular treatment devices that can be delivered to, and oriented correctly at, a desired location within a patient. The guidewire functionality assists greatly in properly positioning the treatment devices.


Aspects of the invention provide a device that includes an impeller dimensioned for insertion into vasculature of a patient, a guidewire lumen extending through the impeller, and a drive mechanism operable to rotate the impeller while the impeller is in the vasculature with a guidewire extending through the lumen. The drive mechanism may include a hollow driveshaft extending proximally from the impeller to a motor. The hollow driveshaft may extend through a catheter having a proximal portion and a distal portion, in which the impeller is distal to the distal portion and the motor is proximal to the proximal portion. In some embodiments, the motor sits in a housing connected to the proximal portion of the catheter. The motor may include a stator housed within the housing and a rotor disposed within the stator, wherein the guidewire lumen extends through the impeller, through the driveshaft, and through the rotor.


In certain embodiments, the guidewire lumen opens to a tapered port at a proximal portion of the housing. The device may include a hollow atraumatic tip extending distally from the impeller.


In some embodiments, the hollow driveshaft extends through an extended catheter, in which the impeller is disposed at a distal portion of the catheter and the motor is disposed at a proximal portion of the catheter. The device may include an impeller housing connected to the distal portion of the catheter and may include at least one inlet port proximal to the impeller and at least one outlet port distal to the impeller, wherein rotation of the impeller impels liquid through the impeller housing. The device may further include an expandable member on the distal portion of the catheter and at least one inflation lumen extending through the catheter.


In some embodiments, the expandable member comprises a substantially toroidal balloon connected to the catheter or impeller housing by an expandable membrane. When the catheter is inserted over a guidewire into the vasculature, the balloon can be inflated and the impeller can be rotated by operation of the motor while the guidewire extends through the device.


By including a purge system, devices of the catheter operate reliably and operation of those device is not interfered with by cells, dead cell fragments and other debris found in bodily fluids. Thus intravascular catheters of the disclosure are easily positioned and operate reliably. The catheters may include treatment devices that are particularly suited to the treatment of edema or congestive heart failure, such as mechanisms that aid in draining a lymphatic system. Since the guidewire aids in positioning the device, and the purge system facilitates reliable operation, intravascular catheters of the disclosure may be used to treat heart failure and edema with positional accuracy and material reliability.


In certain embodiments, the impeller and the drive shaft may define or include a guidewire lumen that extends through the impeller and the drive shaft. The guidewire lumen preferably extends through the motor, such that when the device is inserted into vasculature of a patient over a guidewire, operation of the motor rotates the impeller within the vasculature while the guidewire extends through the guidewire lumen. The device may be operable when the guidewire extends distally out of a distal tip of device. In such embodiments, when the device is inserted into the vasculature of the patient over the guidewire: the purge fluid continually purges the catheter when the motor is operated; and the purge fluid continually purges the catheter when the motor is not operated.


Preferably, when the impeller is inserted into vasculature of a patient, the purge fluid purges the catheter by hydrostatic pressure while the motor is not operated and the purge fluid purges the catheter by centrifugal force while the motor is operated.


In related aspects, the invention provides a device having an impeller disposed at a distal portion of a catheter and dimensioned for insertion into vasculature of a patient. When the impeller is inserted into the vasculature of a patient, a purge fluid purges the catheter by hydrostatic pressure while the impeller is not being rotated and the purge fluid purges the catheter by centrifugal force while the impeller is being rotated.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a device of the disclosure.



FIG. 2 gives a cutaway view of a housing and a distal portion of a catheter of the device.



FIG. 3 shows the proximal section of the device.



FIG. 4 shows the middle section of the device.



FIG. 5 shows the distal section of the device.



FIG. 6 illustrates a device in use for treatment of a patient.



FIG. 7 gives a detail view of the distal portion and distal tip of the catheter.



FIG. 8 is a cross-sectional view through a tube portion of the device.



FIG. 9 diagrams a method of treating a patient using a device of the disclosure.





DETAILED DESCRIPTION


FIG. 1 shows a device 101 with an extended catheter 107, having a proximal portion 106 and a distal portion 108, extending from a housing 105. The catheter 107 is dimensioned for insertion into a bodily lumen, such as a vein of a patient. At a distal portion 108 of the catheter 107, a flexible, atraumatic tip 180 extends past the distal portion 108 of the catheter 107, terminating at a distal tip 181. A guidewire 177 is shown, extending from the distal tip 181 of the device 101.


An infusion channel 123 enters the housing 105, allowing a purge fluid 125 to enter the catheter by the infusion channel 123. As discussed in greater detail below, the device 101 may include one or more expandable members 163, e.g., located at the distal portion 108 of the catheter 107.



FIG. 2 gives a cutaway view of the housing 105 and the distal portion 108 of the catheter 107. The motor housing 105 houses a drive mechanism 130. Embodiments of the drive mechanism 130 include a motor 113 having a rotor 127 disposed within a stator 131. A porous drive shaft 111 extends from a motor 113 through the catheter 107. At least a portion of the drive shaft 111 is housed within a tube 119. The motor 113 comprises a rotor 127 disposed within a stator 131 in a housing 105 at a proximal portion 106 of the catheter 107.


The device 101 includes a porous drive shaft 111 extending from a motor 113 through the catheter 107. A portion of the drive shaft 111 is housed within a tube 119 that may extend from the housing 105 to the distal portion 108.


At the housing 105, an infusion channel 123 is in fluid communication with the porous drive shaft 111 and arranged such that a purge fluid 125 is discharged through the porous drive shaft 111 and towards the distal portion 108.


The distal portion 108 includes the distal end 120 of the tube 119, with an expandable membrane 168 and balloon 164 disposed about the catheter. Distal to the distal end 120 of the tube 119 is an impeller housing 144, housing an impeller 143, and a hollow atraumatic tip 180. The balloon 164 (when inflated), the expandable membrane 168 (which expands when the balloon 164 is inflated), and the impeller housing 144 collectively provide and include at least one inlet port 129 and outlet port 130, which provide a passage through the membrane 168 and impeller housing 144 through which the impeller 143 can pump a fluid such as blood.


The tube 119 extends from a proximal end 118 of the tube 119 (in the housing 105) to a distal end of 120 of the tube 119 (on the distal portion 108 of the catheter 107). The tube 119 surrounds a length of the hollow driveshaft 111 extending from the drive mechanism 130. Specifically, the hollow driveshaft 111 extends from the rotor 127 mounted within the stator 131.


The distal portion 108 includes the impeller 143, dimensioned for insertion into vasculature of a patient. A guidewire lumen 175 extends through the impeller 143. The drive mechanism 130 is operable to rotate the impeller 143 while the impeller 143 is in the vasculature with a guidewire extending through the guidewire lumen 175. Features and devices of the invention may be used in a variety of catheters and treatment devices and may, for example, be incorporated into any of those devices described in U.S. Pat. No. 9,901,722; U.S. Pub. 2016/0331378; U.S. Pub. 2015/0343186; U.S. Pub. 2015-0343136; U.S. Pub. 2017/0197021; Int'l Patent Appl. Pub. WO 2016/181217; Intl Patent Appl. Pub. WO 2015/186005; and Int'l Patent Appl. Pub. WO 2015/186003, the contents of each of which are incorporated by reference.



FIG. 2 includes boxes to call out a proximal section 301 of the device 101, a middle section 401 of the device 101, and a distal section 501 of the device 101.



FIG. 3 shows the proximal section 301 of the device 101. The guidewire lumen 175 extends through the housing 105. A drainer 117 is in fluid communication with an interior space of the housing. At a proximal portion 104 of housing 105, is a Luer 106 providing access to a tapered port 115 that can guide a guidewire into the guidewire lumen 175. One or more sealed bearings 116 may be included to allow rotation of the driveshaft and minimize vibrations of the motor 113. The infusion channel 123 allows purge fluid 125 to enter the catheter 107.



FIG. 4 shows the middle section 401 of the device 101. A proximal end 118 of tube 119 includes a proximal tube seal 135 (a distal tube seal 139 is located at the other end) to seal the tube 119 around the drive shaft 111. The guidewire lumen 175 extends through the drive shaft 111, which connects to the motor 113 via a motor shaft 114. The tube 119 surrounds a sleeve 122 which sits around the drive shaft. The proximal end 118 of the tube 119 includes a proximal tube seal 135 around the drive shaft 111. Operation of the motor 113 rotates the drive shaft 111 within the tube 119.



FIG. 5 shows the distal section 501 of the device 101. The hollow drive shaft 111 terminates at the impeller 143 on an impeller shaft 149. The impeller shaft 149 has one or more through holes 157. The impeller shaft 149 may be seated in one or more distal sealed bearing 166. Extending through the impeller shaft 149 is an impeller shaft lumen 153, which is in fluidic communication with a surrounding environment at least through the one or more through holes 157. The tube 119 ends at the distal tube end 120, where it forms a distal tube seal 139 around the hollow drive shaft 111. The hollow drive shaft 111 and the impeller shaft lumen 153 cooperate to define or include at least a portion of the guidewire lumen 175. The impeller 143 is seated within the impeller housing 144 by means of one or more support rings 150, which may be, for example, open central rings supported within an outer ring by multiple spokes. The impeller 143 has one or a plurality of blades 145 to impel fluid through the impeller housing 144 when the impeller 143 rotates.


With reference back to FIGS. 1-5, the purge fluid 125 may be supplied in a reservoir, e.g., an IV bag, that may hang from a rack to be gravitationally higher than the device 101 when the device 101 is used bedside in a clinical setting. The porous drive shaft 111 is coupled to, and extends from, the rotor 127 of the motor 113. The porous, hollow drive shaft 111 that rotates when the motor 113 operates influences the fate of purge fluid 125 that enters the catheter 107 through the infusion channel 123. When the motor 113 is not rotating, a static pressure of the purge fluid 125 prevents bodily fluid from entering the housing 105. When the motor 113 is rotating, the purge fluid 125 is subject to centrifugal force along the drive shaft 111 preventing bodily fluid from approaching the proximal portion 106 of the catheter 107.


Components described herein thus provide a purge system for an intravascular treatment catheter, particularly for catheters that use rotational mechanisms such as impellers or ablation tools or for over-the-wire catheters that provide instruments that can be inserted into vasculature of a patient over a guidewire. Any suitable purge fluid 125, such as saline, may be used. The described components and features cooperate to prevent bodily fluids from entering the catheter when parts of the catheter are stationary and also when mechanical parts are operating.


In certain embodiments, when the impeller 143 is inserted into vasculature of a patient, the proximal tube seal 135, the tube 119, and/or the distal tube seal 129 separate the purge fluid 125 within the porous drive shaft 111 from blood within the catheter 107 outside of the tube 119. The impeller 143 may include one or more blades 145 disposed along an impeller shaft 149 coupled to the drive shaft 111, in which the impeller shaft 149 has an impeller shaft lumen 153 therethrough and one or more through-holes 157 along a side of the impeller shaft 149 such that rotation of the impeller 143 in a liquid subjects the liquid to centrifugal force at the one or more holes 157. That is, when the impeller 143 is disposed within vasculature of a patient and the motor 113 is operated, the impeller 143 pumps blood and the purge fluid 125 rinses at least a portion of the impeller 143. In such scenario, purge fluid in the catheter 107 (e.g., that flowed in under gravity while the impeller was not operating) would be driven out through the through-holes 157 while the motor 113 operates, thereby securely preventing any bodily fluid from entering the device 101.


The purge system may have particular applicability on devices used in different bodily systems, such as the circulatory system and the lymphatic system. E.g., the purge fluid prevents blood from entering the device 101, so that if the device 101 is subsequently entered into a thoracic duct, blood is not brought into that area.


In certain depicted embodiments, the device 101 includes one or more inflatable balloons 163 disposed along the catheter 107, each in fluid communication with an inflation lumen 164 extending along the catheter 107.


In certain embodiments, the device 101 is designed as an over-the-wire device in that it can be delivered to a location in the vasculature of a patient by following a guidewire that has been navigated to the intended location. Preferably, the impeller 143 and the drive shaft 111 define or include a guidewire lumen 175 that extends through the impeller 143 and the drive shaft 111.


In some embodiments (see, e.g., FIG. 2), the guidewire lumen 175 extends through the motor 113. When the device 101 is inserted into vasculature of a patient over a guidewire 177, operation of the motor 113 rotates the impeller 143 within the vasculature while the guidewire 177 extends through the guidewire lumen 175. In certain embodiments, the device 101 is operable when the guidewire 177 extends distally out of a distal tip 181 of device 101 (that is, even with the guidewire 177 extending out of the distal tip, the motor 113 can be operated to drive the impeller 143). The over-the-wire impeller embodiments of the device 101 may include a purge system. In such embodiments, when the device 101 is inserted into the vasculature of the patient over the guidewire, the purge fluid 125 continually purges the catheter 107 when the motor 113 is operated and the purge fluid 125 continually purges the catheter 107 when the motor 113 is not operated. Preferably, when the impeller 143 is inserted into vasculature of a patient, the purge fluid 125 purges the catheter 107 by hydrostatic pressure while the motor 113 is not operated and the purge fluid 125 purges the catheter by centrifugal force while the motor 113 is operated.


Thus the disclosure provides a device 101 having an impeller 143 disposed at a distal portion 108 of a catheter 107 and dimensioned for insertion into vasculature of a patient, wherein when the impeller 143 is inserted into the vasculature of a patient, a purge fluid 125 purges the catheter 107 by hydrostatic pressure while the impeller 143 is not being rotated and the purge fluid 125 purges the catheter 107 by centrifugal force while the impeller 143 is being rotated.


Additionally, the disclosure provides a device 101 with an impeller 143 dimensioned for insertion into vasculature of a patient, a guidewire lumen 175 extending through the impeller 143, and a drive mechanism 130 operable to rotate the impeller 143 while the impeller 143 is in the vasculature with a guidewire 177 extending through the guidewire lumen 175. The drive mechanism 130 may include a hollow driveshaft 111 extending proximally from the impeller 143 to a motor 113. The hollow driveshaft 111 preferably extends through a catheter 107 having a proximal portion 106 and a distal portion 108, in which the impeller 143 is distal to the distal portion 108 and the motor 113 is proximal to the proximal portion 106 (see, e.g., FIG. 2). In some embodiments, the motor 113 sits in a housing 105 connected to the proximal portion 106 of the catheter 107. The motor 113 may include a stator 131 housed within the housing 105 and a rotor 127 disposed within the stator 131, with the guidewire lumen 175 extending through the impeller 143, through the driveshaft 111, and through the rotor 127. Optionally, the guidewire lumen 175 opens to a tapered port 115 at a proximal portion 104 of the housing 105. The device 101 may include a hollow atraumatic tip 180 extending distally from the impeller 143. The hollow driveshaft 111 may extend through an extended catheter 107, with the impeller 143 disposed at a distal portion 108 of the catheter 107 and preferably with the motor 113 disposed at a proximal portion 106 of the catheter 107.



FIG. 6 illustrates a device 101 in use for treatment of a patient 601. The device 101 has been inserted into vasculature of the patient 601 such that the housing 105 sits outside the patient 601 and the distal portion 108 of the catheter sits in the left jugular vein 611 near the junction with the left subclavian vein 607, thereby servicing an outflow of the thoracic duct 619. The impeller sits over the guidewire 177 and can operate (rotate) while sitting over the guidewire 177. The purge fluid 125 is provided through the catheter and washes the impeller 143 and prevents bodily fluid from entering the device 101.



FIG. 7 gives a detail view of the distal portion 108 and distal tip 180 of the catheter 107 on the device 101. The impeller 143 sits in the impeller housing 144, preferably just downstream of an expandable membrane 168, which is connected to an inflatable balloon 164. When the balloon 164 is inflated, it forms a torus surrounding the catheter 107 and it forms the expandable membrane 168 into a tapered conduit. A proximal end of the expandable membrane 168, ringed by the toroidal balloon 164, forms an inlet port 129 to the conduit, and the conduit continues into the impeller housing 144 to one or more outlet ports 130, which may be disposed along one or more sides of the housing 144. A guidewire 177 may be extended through the device, through the guidewire lumen 175. The impeller 143 is connected to a drive mechanism 130 (not pictured) through a hollow drive shaft 111. A hollow, atraumatic tip 180 sits distal to the impeller and completes the guidewire lumen 175. The guidewire 177 extends from the tip 180. The impeller housing 144 is connected to the distal portion 108 of the catheter 107. As shown, the device 101 includes at least one inlet port 129 proximal to the impeller 143 and at least one outlet port 130 distal to the impeller 143, such that rotation of the impeller 143 impels liquid through the impeller housing 144. For the at least one expandable member 163 (e.g., the balloon 164) on the distal portion 108 of the catheter 107, at least one inflation lumen 160 extends through the catheter 107. As shown, the expandable member 163 may include a substantially toroidal balloon 164 connected to the catheter 107 or impeller housing 144 by an expandable membrane 168. When the catheter 107 is inserted over a guidewire 177 into the vasculature, the balloon 164 can be inflated and the impeller 143 the can be rotated by operation of the motor 113 while the guidewire 177 extends through the device 101.



FIG. 8 is a cross-sectional view through the tube 119, showing the drive shaft 111 extending from the motor 143 to the impeller 143. The tube 119 surrounds a sleeve 122 which sits around the drive shaft 111. The purge fluid 125 arrives through the porous drive shaft 111 and is under either or both of hydrostatic pressure and centrifugal force to prevent blood from entering the catheter.



FIG. 9 diagrams a method 901 of treating a patient that may be performed using a device 101 of the disclosure. The method 901 includes inserting 907 a distal portion 108 of the catheter 107 into vasculature of a patient (over a guidewire 177) and navigating the distal portion 108 to a treatment site, such as an outlet of a thoracic duct 619. The method 901 may include purging 913 the catheter 107 by hydrostatic pressure of the purge fluid 125 while the device sits in the vasculature (e.g., within the jugular vein 611). The device may be operated 925 while over the wire. For example, the impeller 143 may be rotated by driving the motor 113, even while the guide wire 177 extends through the impeller shaft lumen. While the device is operated 925, the device 101 is purged 929 by centrifugal force and other forces of fluid dynamics. The purging 913, 929 by the purge fluid 125 allows the impeller 143 to operate 925 reliably, and the positioning over-the-wire (OTW) places the distal portion 108 in the correct location proximal to an outflow of a thoracic duct 619. By such means, the device 101 decreases 935 pressure at the thoracic duct 619, thereby relieving edema and aiding in the treatment of congestive heart failure.


INCORPORATION BY REFERENCE

References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.


EQUIVALENTS

Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification, and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.

Claims
  • 1. A device comprising: a catheter dimensioned for insertion into a bodily lumen;a motor housing disposed at a proximal portion of the catheter;a motor housed within the motor housing;an impeller housing coupled to a distal portion of the catheter, wherein the impeller housing comprises an impeller disposed therein, the impeller comprising an impeller shaft and one or more blades disposed along the impeller shaft, at least one inlet port proximal to the impeller, and at least one outlet port distal to the impeller such that rotation of the impeller impels fluid through the impeller housing from the at least one inlet port to the at least one outlet port;an inflatable balloon coupled to the impeller housing;a drive shaft extending from the motor through the catheter and connected to the impeller shaft;a tube having at least a portion of the drive shaft housed therein; andan infusion channel in fluid communication with the drive shaft and arranged such that purge fluid is delivered and discharged from the infusion channel through a gap between the impeller and the tube to prevent bodily fluid from entering the tube, wherein when the impeller is disposed within vasculature of a patient the infusion channel is configured to deliver the purge fluid such that, when the motor is operated to rotate the impeller to pump blood through the impeller housing, the purge fluid is discharged through the gap to rinses at least a portion of the impeller and, when the motor is not operating and the impeller is not rotating, the purge fluid is discharged through the gap to purge the catheter via a hydrostatic pressure.
  • 2. The device of claim 1, wherein the motor comprises a rotor disposed within a stator in the motor housing at a proximal portion of the catheter.
  • 3. The device of claim 2, wherein the drive shaft is coupled to, and extends from, the rotor.
  • 4. The device of claim 3, wherein a proximal end of the tube includes a proximal sealed connection around the drive shaft, and further wherein operation of the motor rotates the drive shaft within the tube.
  • 5. The device of claim 4, wherein a distal end of the tube includes a distal sealed connection around the drive shaft.
  • 6. The device of claim 5, wherein when the impeller is inserted into vasculature of a patient, the proximal sealed connection, the tube, and/or the distal sealed connection separate the purge fluid within the drive shaft from blood within the catheter outside of the tube.
  • 7. The device of claim 2, wherein the impeller shaft has an impeller shaft lumen therethrough and one or more holes along a side of the impeller shaft such that rotation of the impeller in a liquid subjects the liquid to centrifugal force at the one or more holes.
  • 8. The device of claim 1, wherein the impeller and the drive shaft define a guidewire lumen that extends through the impeller and the drive shaft.
  • 9. The device of claim 8, wherein the guidewire lumen extends through the motor, further wherein when the device is inserted into vasculature of a patient over a guidewire, operation of the motor rotates the impeller within the vasculature while the guidewire extends through the guidewire lumen.
  • 10. The device of claim 9, wherein the device is operable when the guidewire extends distally out of a distal tip of device.
  • 11. The device of claim 9, wherein when the device is inserted into the vasculature of the patient over the guidewire: the purge fluid continually purges the catheter when the motor is operated; andthe purge fluid continually purges the catheter when the motor is not operated.
  • 12. The device of claim 1, wherein when the motor is rotating, the purge fluid is subject to centrifugal force along the drive shaft preventing the bodily fluid from approaching the proximal portion of the catheter.
  • 13. The device of claim 1, wherein the balloon is in fluid communication with an inflation lumen extending along the catheter.
  • 14. The device of claim 1, wherein when the impeller is inserted into vasculature of a patient, the purge fluid purges the catheter by hydrostatic pressure while the motor is not operated and the purge fluid purges the catheter by centrifugal force while the motor is operated.
  • 15. The device of claim 1, wherein the inflatable balloon, when inflated, forms a torus surrounding the impeller housing.
  • 16. The device of claim 1, wherein the impeller is seated within the impeller housing by at least one support ring, wherein the support ring comprises an open central ring supported within an outer ring by multiple spokes.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a national stage entry of PCT/IB2019/000139, filed Feb. 12, 2019, which claims priority to U.S. Provisional Application No. 62/629,914, filed Feb. 13, 2018, the contents of which are incorporated by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/IB2019/000139 2/12/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/158996 8/22/2019 WO A
US Referenced Citations (231)
Number Name Date Kind
3211150 Foderick Oct 1965 A
3884240 Gilman May 1975 A
3926175 Allen et al. Dec 1975 A
4714460 Calderon Dec 1987 A
4822341 Colone Apr 1989 A
4838864 Peterson Jun 1989 A
4957484 Murtfeldt Sep 1990 A
5005564 Grundei et al. Apr 1991 A
5069662 Bodden Dec 1991 A
5092844 Schwartz et al. Mar 1992 A
5097840 Wallace et al. Mar 1992 A
5366504 Andersen et al. Nov 1994 A
5391143 Kensey Feb 1995 A
5484412 Pierpont Jan 1996 A
5509897 Twardowski et al. Apr 1996 A
5554119 Harrison et al. Sep 1996 A
5558642 Schweich, Jr. et al. Sep 1996 A
5702364 Euteneuer Dec 1997 A
5716340 Schweich, Jr. et al. Feb 1998 A
5817046 Glickman Oct 1998 A
5836912 Kusleika Nov 1998 A
5893841 Glickman Apr 1999 A
5897533 Glickman Apr 1999 A
5908407 Frazee et al. Jun 1999 A
5919163 Glickman Jul 1999 A
5921913 Siess Jul 1999 A
6042569 Finch, Jr. et al. Mar 2000 A
6139517 Macoviak et al. Oct 2000 A
6152945 Bachinski et al. Nov 2000 A
6165196 Stack et al. Dec 2000 A
6179796 Waldridge Jan 2001 B1
6183492 Hart et al. Feb 2001 B1
6245007 Bedingham et al. Jun 2001 B1
6248091 Voelker Jun 2001 B1
6254563 Macoviak et al. Jul 2001 B1
6443884 Miyawaki Sep 2002 B1
6503224 Forman et al. Jan 2003 B1
6524323 Nash et al. Feb 2003 B1
6555057 Bendera Apr 2003 B1
6616623 Kutushov Sep 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6699231 Sterman et al. Mar 2004 B1
6878140 Barbut Apr 2005 B2
6936057 Nobles Aug 2005 B1
7022097 Glickman Apr 2006 B2
7195608 Burnett Mar 2007 B2
7645259 Goldman Jan 2010 B2
7766892 Keren et al. Aug 2010 B2
7780628 Keren et al. Aug 2010 B1
8109880 Pranevicius et al. Feb 2012 B1
8126538 Shuros et al. Feb 2012 B2
8216122 Kung Jul 2012 B2
8480555 Kung Jul 2013 B2
8535211 Campbell Sep 2013 B2
8679057 Fulton, III et al. Mar 2014 B2
9179921 Morris Nov 2015 B1
9405942 Liao et al. Aug 2016 B2
9421316 Leeflang et al. Aug 2016 B2
9433713 Corbett et al. Sep 2016 B2
9486566 Siess Nov 2016 B2
9533054 Yan et al. Jan 2017 B2
9533084 Siess et al. Jan 2017 B2
9642991 Eversull et al. May 2017 B2
9669142 Spanier et al. Jun 2017 B2
9669144 Spanier et al. Jun 2017 B2
9675739 Tanner et al. Jun 2017 B2
9682223 Callaghan et al. Jun 2017 B2
9750861 Hastie et al. Sep 2017 B2
9770543 Tanner et al. Sep 2017 B2
9878080 Kaiser et al. Jan 2018 B2
9901722 Nitzan et al. Feb 2018 B2
9962170 Jansen May 2018 B2
10149684 Nitzan et al. Dec 2018 B2
10154846 Nitzan et al. Dec 2018 B2
10195405 Nitzan et al. Feb 2019 B2
10207086 Nitzan et al. Feb 2019 B2
10226604 Nitzan et al. Mar 2019 B2
10226605 Nitzan et al. Mar 2019 B2
10245363 Rowe Apr 2019 B1
10285708 Nitzan et al. May 2019 B2
10300254 Nitzan et al. May 2019 B2
10639460 Nitzan et al. May 2020 B2
10653871 Nitzan et al. May 2020 B2
10709878 Nitzan et al. Jul 2020 B2
10912873 Nitzan et al. Feb 2021 B2
10926069 Nitzan et al. Feb 2021 B2
10960189 Nitzan et al. Mar 2021 B2
11007353 Gerrans et al. May 2021 B2
11166730 Nitzan et al. Nov 2021 B2
11179550 Nitzan et al. Nov 2021 B2
11179551 Nitzan et al. Nov 2021 B2
11179552 Nitzan et al. Nov 2021 B2
11357959 Nitzan et al. Jun 2022 B2
11406393 Nitzan Aug 2022 B2
20020010418 Lary et al. Jan 2002 A1
20030093109 Mauch May 2003 A1
20030134416 Yamanishi et al. Jul 2003 A1
20030208097 Aboul-Hosn et al. Nov 2003 A1
20040006306 Evans et al. Jan 2004 A1
20040064091 Keren et al. Apr 2004 A1
20040147871 Burnett Jul 2004 A1
20040210296 Schmitt et al. Oct 2004 A1
20040230181 Cawood Nov 2004 A1
20050085772 Zafirelis et al. Apr 2005 A1
20050228474 Laguna Oct 2005 A1
20050251180 Burton et al. Nov 2005 A1
20060030814 Valencia et al. Feb 2006 A1
20060064059 Gelfand et al. Mar 2006 A1
20060100658 Obana et al. May 2006 A1
20060161095 Aboul-Hosn et al. Jul 2006 A1
20060178604 Alderman Aug 2006 A1
20070055299 Ishimaru et al. Mar 2007 A1
20070282303 Nash et al. Dec 2007 A1
20070282382 Shuros et al. Dec 2007 A1
20080009719 Shuros et al. Jan 2008 A1
20080015628 Dubrul et al. Jan 2008 A1
20080071135 Shaknovich Mar 2008 A1
20080097412 Shuros et al. Apr 2008 A1
20080103573 Gerber May 2008 A1
20080140000 Shuros et al. Jun 2008 A1
20080294228 Brooke et al. Nov 2008 A1
20090018526 Power et al. Jan 2009 A1
20090069829 Shturman Mar 2009 A1
20090112184 Fierens et al. Apr 2009 A1
20090131785 Lee et al. May 2009 A1
20100168649 Schwartz et al. Jul 2010 A1
20100179389 Moroney, III et al. Jul 2010 A1
20100280451 Teeslink et al. Nov 2010 A1
20100318114 Pranevicius et al. Dec 2010 A1
20110004046 Campbell et al. Jan 2011 A1
20110092955 Purdy et al. Apr 2011 A1
20110257462 Rodefeld et al. Oct 2011 A1
20110276023 Leeflang et al. Nov 2011 A1
20110282274 Fulton, III Nov 2011 A1
20110295302 Mohl Dec 2011 A1
20120029466 Callaghan et al. Feb 2012 A1
20120157913 Aziz et al. Jun 2012 A1
20120178986 Campbell et al. Jul 2012 A1
20120259215 Gerrans et al. Oct 2012 A1
20130096476 Rogachevsky Apr 2013 A1
20130096494 Kassab Apr 2013 A1
20130138041 Smisson, III et al. May 2013 A1
20130177432 Toellner et al. Jul 2013 A1
20130237954 Shuros et al. Sep 2013 A1
20130245607 Eversull et al. Sep 2013 A1
20130303831 Evans Nov 2013 A1
20130303969 Keenan et al. Nov 2013 A1
20130317535 Demmy Nov 2013 A1
20130331814 Fulton, III et al. Dec 2013 A1
20130338559 Franano et al. Dec 2013 A1
20140010686 Tanner et al. Jan 2014 A1
20140128659 Heuring et al. May 2014 A1
20140142616 Smith May 2014 A1
20140155815 Fulton, III et al. Jun 2014 A1
20140220617 Yung et al. Aug 2014 A1
20140243790 Callaghan et al. Aug 2014 A1
20140249386 Caron et al. Sep 2014 A1
20140296615 Franano Oct 2014 A1
20140303461 Callaghan et al. Oct 2014 A1
20140336551 Mantese et al. Nov 2014 A1
20140358036 Holmes Dec 2014 A1
20150051634 Kravik et al. Feb 2015 A1
20150157777 Tuval et al. Jun 2015 A1
20150164662 Tuval Jun 2015 A1
20150238671 Mesallum Aug 2015 A1
20150283360 Kelly Oct 2015 A1
20150306360 Tischler Oct 2015 A1
20150343136 Nitzan et al. Dec 2015 A1
20150343186 Nitzan et al. Dec 2015 A1
20160022890 Schwammenthal et al. Jan 2016 A1
20160045203 Pollock Feb 2016 A1
20160051741 Schwammenthal et al. Feb 2016 A1
20160129266 Schmidt May 2016 A1
20160166463 Douglas et al. Jun 2016 A1
20160169630 Augustine et al. Jun 2016 A1
20160213826 Tanner Jul 2016 A1
20160331378 Nitzan et al. Nov 2016 A1
20170014563 Khir Jan 2017 A1
20170095395 Wennen et al. Apr 2017 A1
20170197021 Nitzan et al. Jul 2017 A1
20170224512 Hingston Aug 2017 A1
20170319764 Tanner et al. Nov 2017 A1
20180012630 Thomee et al. Jan 2018 A1
20180125499 Nitzan et al. May 2018 A1
20180126130 Nitzan et al. May 2018 A1
20180146968 Nitzan et al. May 2018 A1
20180169312 Barry Jun 2018 A1
20180185622 Nitzan et al. Jul 2018 A1
20180193614 Nitzan et al. Jul 2018 A1
20180193615 Nitzan et al. Jul 2018 A1
20180193616 Nitzan et al. Jul 2018 A1
20180250456 Nitzan Sep 2018 A1
20180303986 Meacham Oct 2018 A1
20190014991 Maki et al. Jan 2019 A1
20190046706 Aboul-Hosn et al. Feb 2019 A1
20190046707 Aboul-Hosn et al. Feb 2019 A1
20190083761 Nitzan et al. Mar 2019 A1
20190117943 Nitzan et al. Apr 2019 A1
20190117944 Nitzan et al. Apr 2019 A1
20190126014 Kapur et al. May 2019 A1
20190167878 Rowe Jun 2019 A1
20190223877 Nitzan et al. Jul 2019 A1
20190366063 Nitzan et al. Dec 2019 A1
20200016383 Nitzan et al. Jan 2020 A1
20200030586 Nitzan et al. Jan 2020 A1
20200030587 Nitzan et al. Jan 2020 A1
20200046372 Nitzan Feb 2020 A1
20200206485 Nitzan et al. Jul 2020 A1
20200230380 Nitzan et al. Jul 2020 A1
20200230381 Nitzan et al. Jul 2020 A1
20200261706 Nitzan et al. Aug 2020 A1
20200268951 Nitzan et al. Aug 2020 A1
20200268952 Nitzan et al. Aug 2020 A1
20200268954 Nitzan et al. Aug 2020 A1
20200269025 Nitzan et al. Aug 2020 A1
20200276369 Nitzan et al. Sep 2020 A1
20200306436 Tanner et al. Oct 2020 A1
20200397963 Nitzan et al. Dec 2020 A1
20210121678 Nitzan et al. Apr 2021 A1
20210378676 Keating et al. Dec 2021 A1
20210378677 Keating et al. Dec 2021 A1
20210378678 Keating et al. Dec 2021 A1
20210379329 Keating et al. Dec 2021 A1
20220039803 Nitzan et al. Feb 2022 A1
20220104827 Keating et al. Apr 2022 A1
20220104828 Keating et al. Apr 2022 A1
20220218360 Nitzan et al. Jul 2022 A1
20220218961 Nitzan et al. Jul 2022 A1
20220280761 Nitzan et al. Sep 2022 A1
20220280762 Nitzan et al. Sep 2022 A1
20220331510 Amstutz et al. Oct 2022 A1
Foreign Referenced Citations (20)
Number Date Country
0526102 Feb 1993 EP
2353501 Aug 2011 EP
2353503 Aug 2011 EP
2353632 Aug 2011 EP
2497524 Sep 2012 EP
2637927 Sep 2013 EP
8904193 May 1989 WO
2000024337 May 2000 WO
01013983 Mar 2001 WO
2012135834 Oct 2012 WO
2013025826 Feb 2013 WO
2013061281 May 2013 WO
2014141284 Sep 2014 WO
2015186003 Dec 2015 WO
2017087556 May 2017 WO
2018158636 Sep 2018 WO
2018172848 Sep 2018 WO
2018202776 Nov 2018 WO
2019027380 Feb 2019 WO
2020174285 Sep 2020 WO
Non-Patent Literature Citations (13)
Entry
Bannon, 2011, Anatomic considerations for central venous cannulation, Risk Manag Healthc Policy 4:27-39.
Moscucci, 2014, Section III Hemodynamic principles 10 Pressure measurement, 223-244 in Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention 8 Ed.
Shimizu, 2014, Embolization of a fractured central venous catheter placed using the internal jugular apporach, Int J Surg Case Rep 5:219.
Stone, 2010, The effect of rigid cervical collars on internal jugular vein dimensions, Acad Emerg Med 17(1):100-102.
Swan, 1970, Catheterization of the Heart in Man with Use of a Flow-directed Balloon-tipped Catheter, NEJM 283(9):447-451.
Yancy, 2013, 2013 ACCF/AHA Guideline for the Management of Heart Failure, Circulation 128(16):e240-e327.
Biran, 2017, Heparin coatings for improving blood compatibility of medical devices, Adv Drug Delivery Rev, 112:12-23.
Shimizu, 2014, Embolization of a fractured central venous catheter placed using the internal jugular apporach, Int J Surg Case Rep 5:219-221.
Webb, 2012, Roughness parameters for standard description of surface nanoarchitecture, Scanning 34:257-263.
Blitz, 2014, Pump thrombosis—a riddle wrapped in a mystery inside an enigma, Ann Cardiothorac Surg, 3(5):450-471.
Chikly, 2005, Manual techniques addressing the lymphatic system: origins and development, JAOA 105(10):457-464.
Ratnayake, 2018, The Anatomy and physiology of the terminal thoracic duct and ostial valve in health and disease: potential implications for intervention, J Anat 233:1-14.
Tchantchaleishvili, 2014, Evaluation and treatment of pump thrombosis and hemolysis, Ann Cardiothorac Surg, 3(5):490-495.
Related Publications (1)
Number Date Country
20200397963 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
62629914 Feb 2018 US